botox

Allergan agreed to pay $600 million for Botox’s marketing getting ahead of approved uses. But the F.D.A.

Allergan agreed to pay $600 million to settle charges that it illegally promoted and sold Botox for unapproved uses.

Barely a week after the Food and Drug Administration cleared the way for a second anti-wrinkle drug, the maker of Botox is defending its product, warning physicians about the risks of switching between the two drugs.

Botox has become a wrinkle-removal gold mine for the drug maker Allergan, but some doctors are also now using it to treat ailments like migraines and oily skin.